Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;22(3):235-248.
doi: 10.4196/kjpp.2018.22.3.235. Epub 2018 Apr 25.

Ursolic acid in health and disease

Affiliations
Review

Ursolic acid in health and disease

Dae Yun Seo et al. Korean J Physiol Pharmacol. 2018 May.

Abstract

Ursolic acid (UA) is a natural triterpene compound found in various fruits and vegetables. There is a growing interest in UA because of its beneficial effects, which include anti-inflammatory, anti-oxidant, anti-apoptotic, and anti-carcinogenic effects. It exerts these effects in various tissues and organs: by suppressing nuclear factor-kappa B signaling in cancer cells, improving insulin signaling in adipose tissues, reducing the expression of markers of cardiac damage in the heart, decreasing inflammation and increasing the level of anti-oxidants in the brain, reducing apoptotic signaling and the level of oxidants in the liver, and reducing atrophy and increasing the expression levels of adenosine monophosphate-activated protein kinase and irisin in skeletal muscles. Moreover, UA can be used as an alternative medicine for the treatment and prevention of cancer, obesity/diabetes, cardiovascular disease, brain disease, liver disease, and muscle wasting (sarcopenia). In this review, we have summarized recent data on the beneficial effects and possible uses of UA in health and disease managements.

Keywords: Disease; Exercise; Health; Irisin; Ursolic acid.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1. Structure of ursolic acid.
Fig. 2
Fig. 2. Role of UA in various organs.
UA supplementation or treatment can provide positive health outcomes via diverse molecular signaling and mechanisms under various diseases in multiple organs such as cancer cells, adipose tissue, heart, blood vessel, brain, liver, and skeletal muscle. NF-kB, nuclear factor-kappa B; cyclin D1; MMP, matrix metalloproteinase; VEGF, vascular endothelial growth factor; ICAM-1, intercellular adhesion molecule-1; CD31, cluster of differentiation 31; STAT3, signal transducer and activator of transcription 3; EGFR, epidermal growth factor receptor; AMPK, AMP-activated protein kinase; JNK, c-Jun N-terminal kinase; GLUT 4, glucose transporter 4; GSK-3β, glycogen synthase kinase 3 beta; HR, heart rate; MAP, mean arterial pressure; TBARS, thiobarbituric reactive substances; CK, creatine kinase; CK-MB, creatine kinase-myocardial band; LDH, lactate dehydrogenease; cTnT, cardiac troponins T; cTnI, cardiac troponin I; HP, lipid hydroperoxides; CD, conjugated dienes; TNF-α, tumor necrosis factor-α; Fas, fatty acid synthase; COX-2, cyclooxygenase; iNOS, inducible nitric oxide synthase; IL-1β, interleukin-1 beta; IL-6, interleukin-6; GSH, glutathione; GSSH, oxidized glutathione; SOD, superoxide dismutase; PPAR, peroxisome proliferator-activated receptors; AST, aspartate aminotransferase; ALT, alanine transaminase; SREBP, sterol regulatory element-binding protein; ACC, acetyl-coA carboxylase; FAS, fatty acid synthase; ROS, reactive oxygen species; PPAR-α, peroxisome proliferator-activated receptor alpha; CPT-1, carnitine palmitoyltransferase 1; MuRF1, muscle ring-finger protein-1; SIRT-1, sirtuin-1 and PGC-1α, peroxisome proliferator-activated receptor-γ coactivator 1α; IGF-1, insulin-like growth factor-1.

References

    1. García AC, de Souza LG, Pereira MG, Castro RN, García-Mina JM, Zonta E, et al. Structure-property-function relationship in humic substances to explain the biological activity in plants. Sci Rep. 2016;6:20798. - PMC - PubMed
    1. Sehrawat A, Roy R, Pore SK, Hahm ER, Samanta SK, Singh KB, Kim SH, Singh K, Singh SV. Mitochondrial dysfunction in cancer chemoprevention by phytochemicals from dietary and medicinal plants. Semin Cancer Biol. 2017;47:147–153. - PMC - PubMed
    1. Diarra M, El Ouahabi H, Bouxid H, Boujraf S, Khabbal Y, Ajdi F. Medicinal plants in type 2 diabetes: therapeutic and economical aspects. Int J Prev Med. 2016;7:56. - PMC - PubMed
    1. de Freitas Junior LM, de Almeida EB., Jr Medicinal plants for the treatment of obesity: ethnopharmacological approach and chemical and biological studies. Am J Transl Res. 2017;9:2050–2064. - PMC - PubMed
    1. Croft KD, Yamashita Y, O'Donoghue H, Shirasaya D, Ward NC, Ashida H. Screening plant derived dietary phenolic compounds for bioactivity related to cardiovascular disease. Fitoterapia. 2017 doi: 10.1016/j.fitote.2017.12.002. [Epub ahead of print] - DOI - PubMed